Breakthrough in Understanding Mycotoxin Toxicity

Aflatoxin B1, commonly abbreviated as AFB1, is a potent mycotoxin produced by certain molds that contaminate crops worldwide. New research published in the journal Food and Chemical Toxicology has identified a key molecular player in how this toxin damages kidney cells in pigs. The study, titled CXCL8 is associated with aflatoxin B1–triggered injury and caspase-3 activation in porcine kidney epithelial PK15 cells: integrated transcriptomics and CRISPR/Cas9 knockout, demonstrates that the chemokine CXCL8 plays a significant role in amplifying cellular injury and promoting programmed cell death through caspase-3 pathways.

The work was led by a team including Jianlin Yuan, Yuhan Ma, Jinfeng Li, Xizhu Chen, Yiping Wen, Rui Wu, Xinfeng Hang, Heng Huang, Senyan Du, Yiping Wang, Qi-Gui Yan, Xiaobo Huang, Fei Zhao, Zheng Yi, San-Jie Cao, and Qin Zhao. Their findings offer fresh insights into the mechanisms of nephrotoxicity and highlight potential targets for mitigating the effects of AFB1 exposure in livestock and beyond. The full publication is available at https://www.sciencedirect.com/science/article/abs/pii/S0278691526003108.

Background on Aflatoxin B1 and Its Global Impact

AFB1 ranks among the most toxic natural compounds known. Produced primarily by Aspergillus flavus and Aspergillus parasiticus fungi, it thrives in warm, humid environments and frequently contaminates staples such as corn, peanuts, and tree nuts. The International Agency for Research on Cancer classifies AFB1 as a Group 1 human carcinogen. In agriculture, it poses severe risks to animal health, particularly in swine production where pigs exhibit high sensitivity. Exposure can lead to reduced growth rates, immune suppression, liver damage, and increasingly recognized kidney injury. Global efforts to monitor and control AFB1 levels in feed remain critical for food safety and economic stability in the livestock sector.

While the liver has long been viewed as the primary target organ, evidence continues to mount that the kidneys are also highly vulnerable. Oxidative stress, mitochondrial dysfunction, and inflammatory signaling contribute to renal epithelial damage. In vitro models like the PK15 cell line, derived from porcine kidney epithelium, provide a reliable platform for dissecting these processes without the ethical and logistical complexities of whole-animal studies.

The PK15 Cell Model and Prior Research

PK15 cells serve as a standard in vitro system for nephrotoxicity investigations. Previous work has shown that AFB1 exposure triggers dose-dependent declines in cell viability, elevated reactive oxygen species, and activation of apoptotic pathways. Studies combining AFB1 with other mycotoxins, such as T-2 toxin, have revealed synergistic effects on oxidative stress and cellular damage in both PK15 cells and mouse kidney tissues. These models help researchers understand how toxins disrupt cellular homeostasis step by step: first through uptake and metabolic activation, then through generation of harmful byproducts that overwhelm antioxidant defenses like glutathione, ultimately leading to mitochondrial impairment and caspase activation.

CXCL8, also known as interleukin-8 or IL-8, is a small chemokine that recruits immune cells and participates in inflammatory responses. Emerging data link its upregulation to various toxic insults, including heavy metal exposure in renal cells. Earlier experiments using the same PK15 line demonstrated that CXCL8 knockout via CRISPR/Cas9 increased resistance to another bacterial toxin, suggesting a broader pro-injury role for this molecule under stress conditions.

Study Design and Integrated Methods

Researchers exposed PK15 cells to a range of AFB1 concentrations from 0 to 32 micromolar for 24 hours. Cell viability assays identified sub-lethal doses of 4 and 8 micromolar as suitable for mechanistic studies. RNA sequencing at the 4 micromolar level served as an unbiased screen to identify transcripts most strongly altered by the toxin. CXCL8 stood out as the most highly induced gene, prompting targeted validation.

To test causality, the team employed CRISPR/Cas9 gene editing to create stable CXCL8 knockout PK15 lines. Wild-type and knockout cells were then compared across multiple endpoints: viability measurements, flow cytometry for apoptosis markers such as Annexin V and propidium iodide, transmission electron microscopy for mitochondrial morphology, assays for reactive oxygen species and glutathione levels, quantitative PCR for BCL2/BAX ratios, and western blotting for caspase-3 protein levels and cleavage.

Photo by Artfox Photography on Unsplash

Key Findings from Transcriptomics and Functional Validation

AFB1 treatment produced clear dose-dependent cytotoxicity, with significant viability loss beginning at 4 micromolar. Morphological changes included cell shrinkage and detachment. RNA sequencing revealed widespread transcriptional reprogramming, with CXCL8 showing the strongest induction among screened genes.

CRISPR-mediated CXCL8 deficiency conferred substantial protection. Knockout cells maintained higher viability, exhibited fewer apoptotic cells, and displayed preserved mitochondrial ultrastructure compared with wild-type counterparts. Oxidative stress markers improved markedly: reactive oxygen species accumulation decreased while glutathione levels were partially restored. The transcriptional balance between anti-apoptotic BCL2 and pro-apoptotic BAX shifted favorably, and both the expression and proteolytic activation of caspase-3 were significantly reduced.

Collectively, these results position CXCL8 as an AFB1-responsive susceptibility factor that amplifies oxidative damage and drives caspase-3-dependent apoptosis in porcine renal epithelial cells. The upstream signals regulating CXCL8 induction and the precise downstream effectors linking it to mitochondrial injury warrant additional investigation in more complex renal models.

Implications for Veterinary Science and Food Safety

These findings advance understanding of how AFB1 exerts nephrotoxic effects in a species of major agricultural importance. Pigs serve as both an economic asset and a translational model for mammalian responses to mycotoxins. Identifying CXCL8 as a modifiable factor opens avenues for targeted interventions, such as nutritional strategies or pharmacological modulators that dampen excessive chemokine signaling during contamination events.

Beyond livestock, the work contributes to broader knowledge of chemokine-mediated toxicity. Similar pathways may operate in human kidney cells exposed to environmental toxins, informing risk assessment and public health measures in regions with high AFB1 prevalence. Regulatory bodies continue to set strict limits on aflatoxin residues in food and feed; mechanistic studies like this support evidence-based refinements to those standards.

Broader Context in Toxicology Research

Mycotoxin research integrates transcriptomics, gene editing, and classical toxicology to move from correlation to causation. The combination of unbiased RNA sequencing with precise CRISPR knockouts exemplifies modern approaches that accelerate discovery while minimizing off-target effects. Funding support from Sichuan Province’s swine industry initiatives underscores the applied relevance of such work to regional agricultural priorities.

Similar gene-editing strategies have proven valuable in other contexts, from enhancing disease resistance in livestock to modeling human conditions. The current study builds directly on prior CXCL8 knockout work in the same cell line, demonstrating reproducibility and expanding the toxin repertoire under investigation.

Future Directions and Research Opportunities

Further studies could explore the regulatory networks controlling CXCL8 expression under AFB1 stress, test additional renal cell types or organoid models, and evaluate in vivo outcomes in pigs fed contaminated diets. Investigating interactions with other mycotoxins or environmental stressors would also strengthen predictive models of combined exposures.

For researchers and trainees, projects of this nature highlight growing demand for expertise in functional genomics, oxidative stress biology, and veterinary toxicology. Laboratories worldwide seek scientists skilled in CRISPR applications, high-throughput sequencing analysis, and cell-based toxicity assays. Such work often leads to collaborative networks spanning academia, industry, and regulatory agencies.

Photo by Luis Andrés Villalón Vega on Unsplash

Connecting Research to Academic Careers

Discoveries like this one illustrate the tangible impact of sustained investment in basic and applied research. Early-career researchers can build profiles through contributions to high-impact publications in journals such as Food and Chemical Toxicology. Opportunities exist in postdoctoral positions focused on mycotoxin mechanisms, faculty roles in veterinary colleges, and industry positions developing feed additives or diagnostic tools.

Institutions continue to expand programs in animal health sciences, offering pathways for PhD candidates interested in translating cellular findings into herd-level solutions. Resources on academic career development, including guidance on publishing and grant writing, support those entering this dynamic field.

Conclusion

The identification of CXCL8 as a critical mediator of AFB1-induced kidney epithelial injury marks an important step forward. By integrating comprehensive transcriptomic profiling with targeted gene knockout, the research team has provided compelling evidence linking this chemokine to oxidative stress amplification and caspase-3 activation. The study, conducted by Jianlin Yuan and colleagues and published in September 2026, equips the scientific community with new mechanistic understanding and actionable hypotheses for protecting animal and potentially human health from mycotoxin threats. Continued exploration of these pathways promises to yield practical strategies for safer food production systems globally.